Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
7.24
-0.02 (-0.28%)
Mar 28, 2025, 4:10 PM AEST

Mayne Pharma Group Market Cap

Mayne Pharma Group has a market cap or net worth of 588.22 million as of March 28, 2025. Its market cap has increased by 6.47% in one year.

Market Cap
588.22M
Enterprise Value
503.17M
Revenue
413.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.24

Market Cap Chart

Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 588.22M, an increase of 1,188.28%. That is a compound annual growth rate of 15.48%.

History

DateMarket Cap% Change
Mar 28, 2025588.22M45.67%
Dec 31, 2024403.79M-19.19%
Dec 29, 2023499.66M43.60%
Dec 30, 2022347.96M-33.16%
Dec 31, 2021520.63M-10.12%
Dec 31, 2020579.28M-20.69%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 122.22B
Pro Medicus 21.09B
Cochlear 17.48B
Sonic Healthcare 12.38B
Telix Pharmaceuticals 9.35B
Ramsay Health Care 8.04B
Ansell 4.94B
Mesoblast 2.73B
Market Cap Rankings